A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.

The U.K. is in the midst of a falling out with big pharma over drug pricing. Merck has walked away from a £1 billion facility in London and pulled its research activities…

Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears

A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.